ALEMBIC LACOSAMIDE lacosamide 150 mg film-coated tablet blister pack

Land: Australien

Språk: engelska

Källa: Department of Health (Therapeutic Goods Administration)

Aktiva substanser:

lacosamide, Quantity: 150 mg

Tillgänglig från:

Alembic Pharmaceuticals Australia Pty Ltd

Läkemedelsform:

Tablet, film coated

Sammansättning:

Excipient Ingredients: magnesium stearate; crospovidone; hyprolose; colloidal anhydrous silica; microcrystalline cellulose; titanium dioxide; hypromellose; purified talc; iron oxide yellow; macrogol 6000; iron oxide red; iron oxide black; macrogol 400

Administreringssätt:

Oral

Enheter i paketet:

14, 56

Receptbelagda typ:

(S4) Prescription Only Medicine

Terapeutiska indikationer:

Alembic Lacosamide (lacosamide) tablets are indicated as: ? monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older. ? add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older. ? add-on therapy in the treatment of primary generalised tonic-clonic seizures in patients with idiopathic generalised epilepsy aged 4 years and older.

Produktsammanfattning:

Visual Identification: Salmon, oval, film-coated tablets debossed with "L425" on one side and plain on other side; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Bemyndigande status:

Registered

Tillstånd datum:

2021-05-11